FDA Law Blog
4,002 FOLLOWERS
A blog by Food and Drug Attorneys at Hyman, Phelps & McNamara, P.C. Blog posts cover FDA News, Orphan Drugs, Animal Drugs & Feeds, cGMP Compliance, Dietary Supplements, Health Privacy, Reimbursement, and Orphan Drugs.
FDA Law Blog
1w ago
Come together with leaders from the pharmaceutical, biotechnology, and diagnostic industries to unpack huge changes at the American Conference Institute’s 23rd Advanced Summit on Life Sciences Patents, which is scheduled to take place from May 19-20, 2025 at the New York Bar Association in New York, NY. In a year of major change and outstanding questions, growing scrutiny on patent protection and drug pricing, and uncertainty around global price control measures and the Inflation Reduction Act, understanding the implications of new leadership and emerging mandates is critical.
Gain ..read more
FDA Law Blog
1w ago
By Andrew J. Hull & David B. Clissold & Sophia R. Gaulkin & Esther Petrikovsky ..read more
FDA Law Blog
1w ago
Hyman, Phelps & McNamara (HPM) marks its 45th Anniversary year by welcoming three accomplished professionals who reinforce the depth and breadth of the firm’s FDA and DEA practices.
Naomi Lowy joins HPM as a Principal Drug Regulatory Expert after 18 years at the FDA’s Center for Drug Evaluation and Research (CDER), most recently as the Deputy Director, Division of General Endocrinology. Dr. Lowy previously served as the Deputy Director, Division of Anesthesiology, Addition and Pain Medicine and the Associate Director for Regulatory Science, Office of Drug Evaluation 1, CDER.
Andrew H ..read more